TIGIT and glioblastoma: Hung and colleagues used murine GBM models to demonstrate blocking both PD-1 and T cell immunoreceptor with Ig and ITIM domains (TIGIT), which is upregulated specifically in the GBM and cervical lymph nodes of both humans and mice, and demonstrated increased survival over PD-1 blockade alone [233].